Business
Lagos Marriott Hotel bags Hotel of the Year award
The Lagos Marriott Hotel, Ikeja has been selected as the winner of the 2022 Hotel of the Year for Sub-Saharan for its unique services among its peers.
This award was given by the parent company – Marriott International at the just concluded 2023 GM’s Conference held in Abu Dhabi.
The Hotel has achieved this milestone award in less than 2 years of operations despite the many challenges of doing business in this climate.
READ ALSO: NCC accelerates broadband penetration to business owners
The Lagos Marriott Hotel Ikeja outperformed over 90 Marriott International hotels within the Sub-Saharan region in key performance indicators such as Gross Operating Profit, Guest Satisfaction index and a total sales up by over 45% versus budget. Another important factor that gave the hotel its win included achieving 39% of women in leadership positions within the hotel.
The owning company – Sifax Group and Macfolly Hospitality LTD are very elated at this recognition and look forward to many more wins such as this.
Lagos Marriott Hotel Ikeja located in the heart of GRA, Ikeja sets a new standard as a 5 star conference hotel showcasing inspiring and contemporary décor within the capital of Nigeria’s commercial hub.
The Hotel is ideally suited for both business and leisure travellers to Lagos providing impeccable service worthy of the Marriott brand.
-
Football1 week agoXabi Alonso targets Arda Guler as Chelsea prepare €100m transfer bid
-
Football1 week agoFIFA confirms Jay-Jay Okocha holds World Cup record
-
Business7 days agoDangote cuts petrol, diesel prices again to boost affordability, economic activity
-
Aviation1 week agoInside Airport Luggage Theft: Experts warn of rising insider syndicates
-
Politics1 week agoAmuwo Odofin: Umeadi emerges winner of NDC Reps Primary
-
Featured1 week agoPSG edge Arsenal on penalties to retain Champions League crown
-
Football1 week agoChampions League Final: Talking points ahead of Arsenal vs. PSG match
-
Health4 days agoSenate hearing set to review research on COVID-19 vaccines, cancer concerns

